Fundz

Torl Bio Therapeutics reported raising $158 Million in an initial SEC Form D filing, from an offering of $158 Million

PRIVATEApr 17, 2024

Amount Raised

$158 Million

$158 Million sold, per SEC Form D (first sale Apr 4, 2024)

Round Type

Venture

Culver CityBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Who to call at TORL BioTherapeutics, and when

A new round usually means TORL BioTherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TORL BioTherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TORL BioTherapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TORL BioTherapeutics

Location

Culver City, California, United States

About

TORL BioTherapeutics is building a preeminent biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of people with cancer worldwide. Through a strategic partnership with the Slamon Research Lab at UCLA, TORL has exclusive development and commercial rights to a large program of biologics-based drugs for promising, and novel cancer targets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TORL BioTherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsChristine L., Chief Operating Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TORL BioTherapeutics's next move

See what Strategic adds

TORL BioTherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.